You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Induction Combination Therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial (Inavolisib, Phesgo, Placebo)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Jun 7, 2023

Ulcerative Colitis Trial in Hamilton (Fecal microbiota transplantation)

Recruiting
  • Ulcerative Colitis
  • Fecal microbiota transplantation
  • Hamilton, Ontario, Canada
    Hamilton Health Sciences
Aug 23, 2022

Acute Myeloid Leukemia Trial in Kunming (Venetoclax in combination with azacitidine and CAG)

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax in combination with azacitidine and CAG
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Dec 20, 2022

Acute Myeloid Leukemia (AML) Trial in Leipzig (VEN+AZA-5)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Leipzig, Germany
    Universitätsklinikum Leipzig, Klinik und Poliklinik für Hämatolo
Apr 25, 2023

Acute Lymphoblastic Leukemia Trial in New York (Ruxolitinib, Dasatinib, Dexamethasone)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 25, 2022

Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

Recruiting
  • Refractory/Relapse Acute Myeloid Leukemia
  • Kunming, Yunnan, China
    Department of Hematology,920th Hospital of Joint Logistic Suppor
Mar 28, 2023

Acute Myeloid Leukemia Trial in Pittsburgh (mitoxantrone + etoposide + gemtuzumab ozogamicin)

Recruiting
  • Acute Myeloid Leukemia
  • mitoxantrone + etoposide + gemtuzumab ozogamicin
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 9, 2022

Multiple Myeloma Trial in Germany (Teclistamab (Tec), Daratumumab, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Teclistamab (Tec)
  • +4 more
  • Berlin, Germany
  • +8 more
Jan 19, 2023

Gastric Cancer, GastroEsophageal Cancer Trial in Aurora, Colorado Springs, Highlands Ranch (Pembrolizumab, Olaparib,

Recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Aurora, Colorado
  • +2 more
Jan 4, 2023

Leukemia, Myeloid, Acute Trial in Poznan (Liposomal Annamycin, Cytarabine)

Recruiting
  • Leukemia, Myeloid, Acute
  • Bologna, Italy
  • +4 more
Jan 31, 2023

Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (drug, procedure, radiation)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Nab-paclitaxel, cisplatin and Pembrolizumab combination
  • +3 more
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Feb 28, 2022

Acute Myeloid Leukemia (AML) Trial in Tianjin (Quizartinib)

Completed
  • Acute Myeloid Leukemia (AML)
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
Jul 27, 2022

Acute Myeloid Leukemia Trial (Sulfasalazine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Oct 11, 2022

Acute Myeloid Leukemia, Adult Trial in Suzhou (venetoclax combined with decitabine)

Unknown status
  • Acute Myeloid Leukemia, Adult
  • venetoclax combined with decitabine
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Nov 8, 2021

DLBCL Trial in Chicago (Metformin, Rituximab, Cyclophosphamide)

Terminated
Has Results
  • Diffuse Large B-Cell Lymphoma
  • Chicago, Illinois
    Rush University Medical Center
Aug 24, 2021

Hepatitis, Autoimmune, Cholangitis, Liver Cirrhosis, Biliary Trial in Chengdu (Ursodeoxycholic acid combination of

Recruiting
  • Hepatitis, Autoimmune
  • +3 more
  • Ursodeoxycholic acid combination of immunosuppressive agents
  • Ursodeoxycholic Acid
  • Chengdu, Sichuan, China
    West China Hospital
Oct 26, 2021

Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • Lung Cancer Stage III
  • Nivolumab and Chemotherapy
  • +3 more
  • (no location specified)
Aug 15, 2023

Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Ipilimumab)

Terminated
Has Results
  • Renal Cell Carcinoma
  • Nivolumab
  • Ipilimumab
  • Saint Louis, Missouri
  • +11 more
Dec 15, 2022

Rectal Cancer Trial in Spain (Panitumumab, 5Fluorouracil, Oxaliplatin)

Completed
  • Rectal Cancer
  • Elche, Alicante, Spain
  • +10 more
Mar 16, 2022

Crohn Disease, Pediatric Crohns Disease Trial in Worldwide (Azithromycin, Metronidazole, Standard of Care)

Recruiting
  • Crohn Disease
  • Pediatric Crohns Disease
  • San Francisco, California
  • +4 more
Apr 19, 2022

Small Cell Lung Cancer Trial in Lexington (Rucaparib and Nivolumab)

Recruiting
  • Small Cell Lung Cancer
  • Rucaparib and Nivolumab
  • Lexington, Kentucky
    Markey Cancer Center, University of Kentucky
Aug 9, 2021

Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Biospecimen Collection
  • +5 more
  • Buffalo, New York
  • +1 more
Jan 27, 2023

Acute Myeloid Leukaemia Trial in Australia, United States (AZD2811, Azacitidine, Venetoclax)

Terminated
  • Acute Myeloid Leukaemia
  • Denver, Colorado
  • +10 more
Mar 24, 2022

Acute Myelogenous Leukemia, AML Trial in Worldwide (Venetoclax, Cytarabine)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • AML
  • Kansas City, Kansas
  • +8 more
Aug 3, 2022

Small-Cell Lung Cancer Trial in Worldwide (Durvalumab, AZD2811, Carboplatin)

Active, not recruiting
  • Small-Cell Lung Cancer
  • Grand Rapids, Michigan
  • +11 more
Apr 25, 2022